Biotechnology Stocks I Performance Guide: BioCryst Pharmaceuticals, Inc. (BCRX)
BCRX has no dividends
Table and Chart of BCRX Performance
See what a $1,000 investment in BCRX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BCRX Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $7.60 |
| End Date | Dec-01-2023 |
| End Price | $6.15 |
| # Prices | 121 |
| Min Date | Feb-29-2016 |
| Min Price | $1.99 |
| Max Date | Feb-28-2022 |
| Max Price | $16.61 |
| Total Return | -19.08% |
| Annualized Return | -2.08% |
| Current Value of $1,000 Purchase | $809 |
| Number Returns | 7,260 |
| Average Return | 37.98% |
| Number Profitable Returns | 3,676 |
| Percent Profitable Returns | 50.63% |
| Number Unprofitable Returns | 3,584 |
| Percent Unprofitable Returns | 49.37% |
| Profitable to Unprofitable Returns Ratio | 1.03 |
| BCRX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,259,575,000 | Price to Sales | 3.97 |
| Earnings per Share | $-1.2500 |
| PE Ratio | None |
| PE to Growth Ratio | -0.28 |
| Price to Book | 56.59 |
| PRICE DATA | |
| 52 Week High | $12.07 |
| 52 Week Low | $4.83 |
| Analyst Target Price | $14.09 |
| 50-Day Moving Average | $5.91 |
| 200-Day Moving Average | $7.35 |
| FINANCIAL DATA | |
| Revenue per Share | $1.684 |
| Revenue | $317,556,000 |
| Profit Margin | -74.4% |
| Return on Equity | -19.25% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BCRX Compare Returns with S&P 500
BCRX Trendline Chart